Chronic Incretin-based therapy in Cystic Fibrosis (Aim 2)

AddtoAny
Share:

The purpose of this research study is to examine and understand the various mechanisms that contribute to Cystic Fibrosis Related Diabetes and gain a better understanding of potential means to treat Cystic Fibrosis Related Diabetes. Participation will include 6-7 visits over 6 months.

Eligibility and Criteria

IRB #:
13-010324
Study Phase:
Phase II
Eligible Age Range:
18 - 99 Years
Gender:
All
Study Categories: